SEC Form 3 · accession 0001607062-18-000342
GENEREX BIOTECHNOLOGY CORP · GNBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard David Purcell Jr.
Officer — SVP Product Launch & Develop
Period of report
Jan 17, 2017
Accepted (ET)
Oct 15, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001059784
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are benefically owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.